Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses
Launched by SOUTHERN COLLEGE OF OPTOMETRY · Apr 24, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see how well people who are currently satisfied with their Acuvue Oaysis contact lenses can switch to a new type of contact lens called P7A. The goal is to find out if these new lenses can provide the same or better comfort for everyday wear.
To be eligible for this study, you need to be between 18 and 40 years old, have good vision, and have been wearing Acuvue Oaysis lenses for at least 3 months. You should also feel satisfied with your current lenses. Participants will wear the new P7A lenses for at least 13 hours a day and will need to come in for a check-up. There are some exclusions, like if you've had certain eye conditions or surgeries, so it's important to check if you qualify. If you join the study, you’ll help researchers learn more about contact lens comfort and potentially improve options for future wearers!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults, 18- to 40-year-old, AOA CL wearers with best-corrected 20/20 visual acuity or better.
- • 2. Participants will be required to have worn AOA CLs for at least 3 months in the past year and currently wearing these CLs.
- • 3. All participants will be required to have a CLDEQ-8 score \<12 while wearing their habitual CLs (AOA CLs) and to indicate that they are satisfied with AOA CLs (Yes/No).
- • 4. Participants will be required to be able to wear P7A CLs (astigmatism ≥0.75D OD/OS).
- • 5. Astigmatism ranging from 0.75 D to 2.50 D in each eye
- • 6. Participants will be required to wear the study CLs for ≥13 hours with no overnight wear
- • 7. Participants will be willing to wear the CL every day of the week, except during the washout period
- • 8. Participants will be required to provide a glasses prescription that is less than 3 years old
- • -
- Exclusion Criteria:
- • 1. Have presbyopia and/or need a reading add as determined during their initial manifest refraction 2. Have worn P7A in the past 3. Are past rigid CL wearers 4. Have a history of being diagnosed with dry eye or ocular allergies 5. Have known systemic health conditions that are thought to alter tear film physiology 6. Have a history of viral eye disease 7. Have a history of ocular surgery 8. Have a history of severe ocular trauma 9. Have a history of corneal dystrophies or degenerations 10. Have active ocular infection or inflammation 11. Are currently using isotretinoin-derivatives or ocular medications 12. Are pregnant or breast feeding
About Southern College Of Optometry
The Southern College of Optometry (SCO) is a leading institution dedicated to advancing the field of optometry through comprehensive education, research, and patient care. With a strong commitment to innovation and excellence, SCO engages in clinical trials aimed at enhancing ocular health and improving vision care outcomes. The college fosters collaboration among students, faculty, and healthcare professionals, leveraging cutting-edge technology and methodologies to contribute valuable insights to the optometric community. Through its rigorous research initiatives, SCO aims to address critical challenges in vision science and establish effective practices that benefit both patients and practitioners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Chris Lievens
Principal Investigator
The Southern College of Optometry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported